These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36745784)

  • 1. Heparin is essential for optimal cell signaling by FGF21 and for regulation of βKlotho cellular stability.
    An SJ; Mohanty J; Tome F; Suzuki Y; Lax I; Schlessinger J
    Proc Natl Acad Sci U S A; 2023 Feb; 120(7):e2219128120. PubMed ID: 36745784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c.
    Suzuki M; Uehara Y; Motomura-Matsuzaka K; Oki J; Koyama Y; Kimura M; Asada M; Komi-Kuramochi A; Oka S; Imamura T
    Mol Endocrinol; 2008 Apr; 22(4):1006-14. PubMed ID: 18187602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate proteoglycan modulates keratinocyte growth factor signaling through interaction with both ligand and receptor.
    LaRochelle WJ; Sakaguchi K; Atabey N; Cheon HG; Takagi Y; Kinaia T; Day RM; Miki T; Burgess WH; Bottaro DP
    Biochemistry; 1999 Feb; 38(6):1765-71. PubMed ID: 10026256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BetaKlotho is required for metabolic activity of fibroblast growth factor 21.
    Ogawa Y; Kurosu H; Yamamoto M; Nandi A; Rosenblatt KP; Goetz R; Eliseenkova AV; Mohammadi M; Kuro-o M
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7432-7. PubMed ID: 17452648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the physical interactions in the FGF21/FGFR/β-Klotho complex: structural requirements and implications in FGF21 signaling.
    Yie J; Wang W; Deng L; Tam LT; Stevens J; Chen MM; Li Y; Xu J; Lindberg R; Hecht R; Véniant M; Chen C; Wang M
    Chem Biol Drug Des; 2012 Apr; 79(4):398-410. PubMed ID: 22248288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonistic β-Klotho antibody mimics fibroblast growth factor 21 (FGF21) functions.
    Min X; Weiszmann J; Johnstone S; Wang W; Yu X; Romanow W; Thibault S; Li Y; Wang Z
    J Biol Chem; 2018 Sep; 293(38):14678-14688. PubMed ID: 30068552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similarities and differences between the effects of heparin and glypican-1 on the bioactivity of acidic fibroblast growth factor and the keratinocyte growth factor.
    Berman B; Ostrovsky O; Shlissel M; Lang T; Regan D; Vlodavsky I; Ishai-Michaeli R; Ron D
    J Biol Chem; 1999 Dec; 274(51):36132-8. PubMed ID: 10593896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracrine-endocrine FGF chimeras as potent therapeutics for metabolic diseases.
    Zhao L; Niu J; Lin H; Zhao J; Liu Y; Song Z; Xiang C; Wang X; Yang Y; Li X; Mohammadi M; Huang Z
    EBioMedicine; 2019 Oct; 48():462-477. PubMed ID: 31631034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors.
    Wu X; Lemon B; Li X; Gupte J; Weiszmann J; Stevens J; Hawkins N; Shen W; Lindberg R; Chen JL; Tian H; Li Y
    J Biol Chem; 2008 Nov; 283(48):33304-9. PubMed ID: 18829467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.
    Kurosu H; Choi M; Ogawa Y; Dickson AS; Goetz R; Eliseenkova AV; Mohammadi M; Rosenblatt KP; Kliewer SA; Kuro-O M
    J Biol Chem; 2007 Sep; 282(37):26687-26695. PubMed ID: 17623664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating diabetes and obesity with an FGF21-mimetic antibody activating the βKlotho/FGFR1c receptor complex.
    Foltz IN; Hu S; King C; Wu X; Yang C; Wang W; Weiszmann J; Stevens J; Chen JS; Nuanmanee N; Gupte J; Komorowski R; Sekirov L; Hager T; Arora T; Ge H; Baribault H; Wang F; Sheng J; Karow M; Wang M; Luo Y; McKeehan W; Wang Z; Véniant MM; Li Y
    Sci Transl Med; 2012 Nov; 4(162):162ra153. PubMed ID: 23197570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of ligand-occupied β-Klotho complexes reveal a molecular mechanism underlying endocrine FGF specificity and activity.
    Kuzina ES; Ung PM; Mohanty J; Tome F; Choi J; Pardon E; Steyaert J; Lax I; Schlessinger A; Schlessinger J; Lee S
    Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7819-7824. PubMed ID: 30944224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The FGFR D3 domain determines receptor selectivity for fibroblast growth factor 21.
    Gupte J; Yang L; Wu X; Weiszmann J; Hecht R; Lemon B; Lindberg R; Wang Z; Li Y
    J Mol Biol; 2011 May; 408(3):491-502. PubMed ID: 21392510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for FGF hormone signalling.
    Chen L; Fu L; Sun J; Huang Z; Fang M; Zinkle A; Liu X; Lu J; Pan Z; Wang Y; Liang G; Li X; Chen G; Mohammadi M
    Nature; 2023 Jun; 618(7966):862-870. PubMed ID: 37286607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho.
    Wu X; Weiszmann J; Ge H; Baribault H; Stevens J; Hawkins N; Vonderfecht S; Gardner J; Gupte J; Sheng J; Wang M; Li Y
    J Mol Biol; 2012 Apr; 418(1-2):82-9. PubMed ID: 22370560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different roles of N- and C- termini in the functional activity of FGF21.
    Micanovic R; Raches DW; Dunbar JD; Driver DA; Bina HA; Dickinson CD; Kharitonenkov A
    J Cell Physiol; 2009 May; 219(2):227-34. PubMed ID: 19117008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation.
    Luo Y; Yang C; Lu W; Xie R; Jin C; Huang P; Wang F; McKeehan WL
    J Biol Chem; 2010 Sep; 285(39):30069-78. PubMed ID: 20657013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Klotho proteins in health and disease.
    Kuro-O M
    Nat Rev Nephrol; 2019 Jan; 15(1):27-44. PubMed ID: 30455427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling.
    Forsten-Williams K; Chua CC; Nugent MA
    J Theor Biol; 2005 Apr; 233(4):483-99. PubMed ID: 15748910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin/Heparan sulfate domains in binding and signaling of fibroblast growth factor 8b.
    Loo BM; Salmivirta M
    J Biol Chem; 2002 Sep; 277(36):32616-23. PubMed ID: 12077148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.